# Repligen

US bioprocessing technology company (RGEN) — XCell ATF alternating tangential flow filtration, KrosFlo TFF systems, Opus pre-packed chromatography columns; leader in single-use perfusion and continuous bioprocessing enabling cell densities >100M cells/mL; strong 2025 recovery after 2023 destocking.

Source: https://en.bioecon.ru/companies/repligen/
Updated: 2026-06-19

- Country: United States
- Revenue: $791M
- Employees: ~2,000 emp

## Technologies

- [Downstream Purification & Bioseparation](https://en.bioecon.ru/technology/downstream-purification-bioseparation/)
- [High-cell-density culture systems](https://en.bioecon.ru/technology/high-cell-density-culture-systems/)